Whole vs Reduced-Fat Milk for Childhood Obesity
(CoMFORT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimizes excess adiposity and optimizes child nutrition and development. CoMFORT will be a parallel group randomized controlled trial among children aged 2 to 4 years participating in the TARGet Kids! practice-based research network. Children will be randomized to receive one of two usual care nutritional recommendations: 1) a recommendation to consume whole milk, or 2) a recommendation to consume reduced (1%) fat milk. The primary outcome is Body Mass Index z-score (zBMI); secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores (serum 25-hydroxyvitamin D), cardiometabolic health (glucose, hsCRP, non-HDL, LDL, triglyceride, HDL and total cholesterol, insulin, and diastolic and systolic blood pressure) and sugar sweetened beverage intake (measured by 24-hour dietary recall). Outcomes will be measured 24 months post-randomization and compared using ANCOVA, adjusting for baseline measures. This trial will contribute to nutrition policy for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is it safe for children to consume whole or reduced-fat milk?
How does the treatment of recommending reduced-fat or whole milk differ from other treatments for childhood obesity?
What data supports the effectiveness of the treatment of different milk fat recommendations for childhood obesity?
Who Is on the Research Team?
Jonathon L Maguire, MD, FRCPC
Principal Investigator
Unity Health Toronto
Are You a Good Fit for This Trial?
This trial is for healthy children aged 1.5 to almost 3 years who are part of the TARGet Kids! network, can communicate in English or French, and regularly consume cow's milk. It excludes those with certain medical conditions like Prader-Willi syndrome, severe developmental delays, lactose intolerance or allergy to cow's milk.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children are randomized to receive either whole milk or reduced fat milk as part of their usual care nutritional recommendations
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Reduced (1%) fat milk
- Whole (3.25%) cow's milk recommendation
Reduced (1%) fat milk is already approved in Canada, United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor
Unity Health Toronto
Collaborator